InnateDB Protein
|
IDBP-5425.5
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
CLN8
|
Protein Name
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
Synonyms
|
C8orf61; EPMR;
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000328182
|
InnateDB Gene
|
IDBG-5421 (CLN8)
|
Protein Structure
|
|
Function |
Could play a role in cell proliferation during neuronal differentiation and in protection against cell death. {ECO:0000269PubMed:19431184}.
|
Subcellular Localization |
Endoplasmic reticulum membrane {ECO:0000269PubMed:10861296}; Multi-pass membrane protein {ECO:0000269PubMed:10861296}. Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000269PubMed:10861296}; Multi-pass membrane protein {ECO:0000269PubMed:10861296}.
|
Disease Associations |
Ceroid lipofuscinosis, neuronal, 8 (CLN8) [MIM:600143]: A form of neuronal ceroid lipofuscinosis with onset in childhood. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 8 comprise mixed combinations of granular, curvilinear, and fingerprint profiles. {ECO:0000269PubMed:15024724, ECO:0000269PubMed:16570191, ECO:0000269PubMed:19201763, ECO:0000269PubMed:19431184, ECO:0000269PubMed:21990111}. Note=The disease is caused by mutations affecting the gene represented in this entry.Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant (CLN8NE) [MIM:610003]: A form of neuronal ceroid lipofuscinosis clinically characterized by epilepsy that presents between 5 and 10 years of age with frequent tonic-clonic seizures followed by progressive mental retardation. Visual loss is not a prominent feature. Intracellular accumulation of autofluorescent material results in curvilinear and granular profiles on ultrastructural analysis. {ECO:0000269PubMed:10508524, ECO:0000269PubMed:21990111}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 31 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Experimentally validated |
Total |
31
[view]
|
Protein-Protein |
31
[view]
|
Protein-DNA |
0
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
Predicted by orthology |
Total |
1 [view]
|
|
|
Molecular Function |
|
Biological Process |
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR006634
TRAM/LAG1/CLN8 homology domain
|
PFAM |
PF03798
|
PRINTS |
|
PIRSF |
|
SMART |
SM00724
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q9UBY8
|
PhosphoSite |
PhosphoSite-
|
TrEMBL |
A0A024QZ57
|
UniProt Splice Variant |
|
Entrez Gene |
2055
|
UniGene |
Hs.127675
|
RefSeq |
NP_061764
|
HUGO |
HGNC:2079
|
OMIM |
607837
|
CCDS |
CCDS5956
|
HPRD |
06383
|
IMGT |
|
EMBL |
AF123757
AF123758
AF123759
AF123760
AF123761
BC007725
BT007049
CH471181
|
GenPept |
AAF13115
AAF13116
AAF13117
AAF13118
AAF13119
AAH07725
AAP35698
EAW51477
EAW51478
EAW51479
|
|
|